CAMBRIDGE, Mass., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically ...
Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. Fulcrum Therapeutics NewsMORE Related Stocks Indices Commodities Currencies Stocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback